The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours

By Chen Gang   Horsman Michael   Pedersen Michael   Pang Qi   Stødkilde-jørgensen Hans  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1071-1076

Informa Healthcare

Access to resources Recommend Favorite

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

By Breidahl Tomas   Nielsen Flemming   Stødkilde-Jørgensen Hans   Maxwell Ross   Horsman Michael  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 306-316

Informa Healthcare

Access to resources Recommend Favorite

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 17, Iss. 6, 2001-11 ,pp. : 508-519

Informa Healthcare

Access to resources Recommend Favorite

Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 20, Iss. 4, 2004-06 ,pp. : 393-404

Informa Healthcare

Access to resources Recommend Favorite

Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor

By Chung Francisco   Wang Liang-Chuan   Kestell Philip   Baguley Bruce   Ching Lai-Ming  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite